Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I A Strokov

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Acta Diabetologica|January 6, 2004
Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control studyI A Strokov, T R Bursa, O I Drepa, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 9, 2008
[Familial amyloid neuropathy associated with the Cys114 mutation of the transthyretin gene in a Russian family]I A Strokov, G M Diukova, A P Pogromov, et al.
Diabetes & Metabolism|March 9, 2006
The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patientsD A Chistiakov, E V Zotova, K V Savost'anov, et al.
Molekuliarnaia Biologiia|May 6, 2004
[Search for the association of polymorphic markers for genes coding for antioxidant defense enzymes, with development of diabetic polyneuropathies in patients with type 1 diabetes mellitus]E V Zotova, K V Savost'ianov, D A Chistiakov, et al.
Molekuliarnaia Biologiia|May 12, 2009
[Association of the T(-365)C POLG1, G(-25)A ANT1 and G(-605)T PEO1 gene polymorphisms with diabetic polyneuropathy in patients with type 1 diabetes mellitus]E V Spitsina, G N Svetlova, D A Chudakova, et al.
Klinicheskaia Meditsina|February 11, 2010
[Familial transthyretin amyloidosis]A P Pogromov, G M Diukova, M O Kovalchuk, et al.
Bulletin of Experimental Biology and Medicine|February 15, 2001
The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapyI A Strokov, E B Manukhina, L Y Bakhtina, et al.
Molekuliarnaia Biologiia|June 21, 2003
[Association of the SOD2 Ala(-9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in patients with diabetes mellitus type 1]E V Zotova, D A Chistiakov, K V Savost'ianov, et al.
Molekuliarnaia Biologiia|March 6, 2008
[Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow]E V Spitsina, N Iu Iakunina, D A Chudakova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 11, 2024
[Role and place of ipidacrine in the therapy of diseases of the peripheral nervous system. The resolution of the expert council]A B Danilov, M L Kukushkin, N A Suponeva, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Acta Diabetologica|January 6, 2004
Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control studyI A Strokov, T R Bursa, O I Drepa, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 9, 2008
[Familial amyloid neuropathy associated with the Cys114 mutation of the transthyretin gene in a Russian family]I A Strokov, G M Diukova, A P Pogromov, et al.
Diabetes & Metabolism|March 9, 2006
The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patientsD A Chistiakov, E V Zotova, K V Savost'anov, et al.
Molekuliarnaia Biologiia|May 6, 2004
[Search for the association of polymorphic markers for genes coding for antioxidant defense enzymes, with development of diabetic polyneuropathies in patients with type 1 diabetes mellitus]E V Zotova, K V Savost'ianov, D A Chistiakov, et al.
Molekuliarnaia Biologiia|May 12, 2009
[Association of the T(-365)C POLG1, G(-25)A ANT1 and G(-605)T PEO1 gene polymorphisms with diabetic polyneuropathy in patients with type 1 diabetes mellitus]E V Spitsina, G N Svetlova, D A Chudakova, et al.
Klinicheskaia Meditsina|February 11, 2010
[Familial transthyretin amyloidosis]A P Pogromov, G M Diukova, M O Kovalchuk, et al.
Bulletin of Experimental Biology and Medicine|February 15, 2001
The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapyI A Strokov, E B Manukhina, L Y Bakhtina, et al.
Molekuliarnaia Biologiia|June 21, 2003
[Association of the SOD2 Ala(-9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in patients with diabetes mellitus type 1]E V Zotova, D A Chistiakov, K V Savost'ianov, et al.
Molekuliarnaia Biologiia|March 6, 2008
[Association of polymorphous markers Pro72Arg and C(-594)CC OF TP53 gene with diabetic polyneuropathy in patients with type 1 diabetes mellitus living in Moscow]E V Spitsina, N Iu Iakunina, D A Chudakova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|March 11, 2024
[Role and place of ipidacrine in the therapy of diseases of the peripheral nervous system. The resolution of the expert council]A B Danilov, M L Kukushkin, N A Suponeva, et al.
Pageof 4